Tetravalent Chimeric Dengue Vaccine Trial

NCT01110551 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

NIH

Sponsor class

Conditions

Dengue

Interventions

DRUG: Placebo (SC)
DRUG: Placebo (ID)
BIOLOGICAL: Modified Live Tetravalent Chimeric Dengue Vaccine (SC)
BIOLOGICAL: Modified Live Tetravalent Chimeric Dengue Vaccine (ID)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)